191 related articles for article (PubMed ID: 9666215)
1. Alendronate in the treatment of osteoporosis.
Adami S
Aging (Milano); 1998 Apr; 10(2):159-60. PubMed ID: 9666215
[No Abstract] [Full Text] [Related]
2. [Quality of life of patients suffering from osteoporosis treated with alendronate and salmon calcitonin].
Sapuła RA; Ostrowski T; Bojar I
Wiad Lek; 2002; 55 Suppl 1():444-7. PubMed ID: 15002282
[TBL] [Abstract][Full Text] [Related]
3. Results of special studies with alendronate.
McClung M
Int J Clin Pract Suppl; 1999 Apr; 101():67-72. PubMed ID: 12669743
[TBL] [Abstract][Full Text] [Related]
4. AACE Clinical Practice Guidelines for the Prevention and Treatment of Postmenopausal Osteoporosis.
J Fla Med Assoc; 1996 Oct; 83(8):552-66. PubMed ID: 9160000
[No Abstract] [Full Text] [Related]
5. Postmenopausal osteoporosis and alendronate.
Pérez-López FR
Maturitas; 2004 Jul; 48(3):179-92. PubMed ID: 15207883
[TBL] [Abstract][Full Text] [Related]
6. [Working title: Will reducing alendronate increase the risk of bone fractures by a decrease in bone density? Benefit from alendronate therapy for women without prior fractures remains uncertain].
Ritzmann P
Praxis (Bern 1994); 1999 Sep; 88(40):1631-2. PubMed ID: 10536501
[No Abstract] [Full Text] [Related]
7. Osteoporosis: a focus on treatment.
Shiflett S; Cooke CE
Md Med J; 1997 Jul; 46(6):303-7. PubMed ID: 9579203
[No Abstract] [Full Text] [Related]
8. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
Iwamoto J; Takeda T; Sato Y
Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic strategies for osteoporosis].
Chapurlat R; Delmas PD
Ann Med Interne (Paris); 2000 Oct; 151(6):471-6. PubMed ID: 11104926
[TBL] [Abstract][Full Text] [Related]
10. [Alendronate in postmenopausal women with osteopenia and osteoporosis: effects on bone mineral density during treatment and after withdrawal].
Jiang Y; Li M; Xia W; Xing X; Yu W; Tian J; Meng X; Zhou X
Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(18):1254-6. PubMed ID: 12425805
[TBL] [Abstract][Full Text] [Related]
11. Do not use bisphosphonate therapy indefinitely for fracture prevention.
Prescrire Int; 2008 Oct; 17(97):214. PubMed ID: 19536944
[TBL] [Abstract][Full Text] [Related]
12. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
Ettinger MP
Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
[TBL] [Abstract][Full Text] [Related]
13. Antiresorptive treatment of postmenopausal osteoporosis: review of randomized clinical studies and rationale for the Evista alendronate comparison (EVA) trial.
Lufkin EG; Sarkar S; Kulkarni PM; Ciaccia AV; Siddhanti S; Stock J; Plouffe L
Curr Med Res Opin; 2004 Mar; 20(3):351-7. PubMed ID: 15025844
[TBL] [Abstract][Full Text] [Related]
14. New possibilities for diagnosis and treatment of osteoporosis.
Miller PD
Int J Fertil Womens Med; 2001; 46(4):215-21. PubMed ID: 11563832
[TBL] [Abstract][Full Text] [Related]
15. Comparison of alendronate, calcitonin and calcium treatments in postmenopausal osteoporosis.
Dursun N; Dursun E; Yalçin S
Int J Clin Pract; 2001 Oct; 55(8):505-9. PubMed ID: 11695068
[TBL] [Abstract][Full Text] [Related]
16. Identifying the osteopenic patient and preventing worsening of the disease.
Derman R
Curr Womens Health Rep; 2003 Jun; 3(3):199-206. PubMed ID: 12734030
[TBL] [Abstract][Full Text] [Related]
17. American Association of Clinical Endocrinologists 2001 Medical Guidelines for Clinical Practice for the Prevention and Management of Postmenopausal Osteoporosis.
American Association of Clinical Endocrinologists Osteoporosis Task Force
Endocr Pract; 2001; 7(4):293-312. PubMed ID: 11508261
[No Abstract] [Full Text] [Related]
18. The antifracture efficacy of alendronate.
Seeman E
Int J Clin Pract Suppl; 1999 Apr; 101():40-5. PubMed ID: 12675021
[TBL] [Abstract][Full Text] [Related]
19. Renal function and bisphosphonate safety.
Ott SM; Drueke T; Elder G; Fukagawa M; Jorgetti V; Langman CB; Moe S; McCann L; Wang AY; Weisinger J; Wheeler D
J Bone Miner Res; 2008 Mar; 23(3):453-4; author reply 455. PubMed ID: 17967135
[No Abstract] [Full Text] [Related]
20. Biological basis of anti-resorptive therapies for osteoporosis.
Zaidi M
Aging (Milano); 1998 Apr; 10(2):157-8. PubMed ID: 9666212
[No Abstract] [Full Text] [Related]
[Next] [New Search]
